secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001104659-25-068098
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma receives Nasdaq delisting notice for bid price non-compliance; schedules Aug 5 reverse split vote
--------------------------------------------------------------------------------

- Nasdaq notified Carisma on July 9, 2025 that failure to regain bid price compliance is an additional delisting basis.
- Listing transferred to Nasdaq Capital Market on June 12, 2025 with exception through Oct 7, 2025 to show compliance.
- Special meeting set for Aug 5, 2025 to approve reverse stock split (1:10 to 1:50) to increase bid price.
- No assurance reverse split will achieve compliance or Panel terms will be met by Oct 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925068098/0001104659-25-068098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925068098/tm2521012d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-068098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer